
CAS 623152-17-0
:BMS 582949
Description:
BMS 582949, with the CAS number 623152-17-0, is a chemical compound that has been studied primarily for its potential therapeutic applications, particularly in the field of oncology. It is classified as a small molecule inhibitor, specifically targeting certain pathways involved in cancer cell proliferation and survival. The compound exhibits selective inhibition of specific kinases, which are enzymes that play crucial roles in various cellular processes, including signal transduction and cell division. BMS 582949 has shown promise in preclinical studies, demonstrating efficacy against certain types of tumors. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Additionally, safety and toxicity profiles are critical factors that researchers evaluate during the drug development process. Overall, BMS 582949 represents a significant area of interest in cancer research, with ongoing studies aimed at understanding its full potential and mechanisms of action.
Formula:C22H26N6O2
Synonyms:- 4-[5-(cyclopropylcarbamoyl)-2-methylanilino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
- CS-2900
- BMS 582949; BMS582949
- PS540446
- BMS 582949
- BMS582949(HCl)
- Pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide, 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propyl-
- 4-[[5-[(Cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
4-((5-(Cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide
CAS:Formula:C22H26N6O2Purity:98%Molecular weight:406.4808BMS582949
CAS:BMS-582949 inhibits p38 MAPK with 13 nM IC50, blocking kinase activity and activation.Formula:C22H26N6O2Purity:98.11%Color and Shape:SolidMolecular weight:406.48BMS-582949
CAS:<p>BMS-582949 is an investigational pharmaceutical compound, specifically a chemokine receptor antagonist, that has been derived through synthetic chemical processes. Its mode of action involves selectively inhibiting the C-C chemokine receptor type 2 (CCR2), a receptor involved in the migration and activation of monocytes and other immune cells. By blocking CCR2, BMS-582949 aims to modulate inflammatory pathways that are implicated in various diseases.</p>Formula:C22H26N6O2Purity:Min. 95%Molecular weight:406.48 g/mol



